COVACERT, created in 2007 (United States), from 142 sister brands and 17477 competing brands. COVACERT is a brand of Amgen, listed on the stock exchange of New York. COVACERT belongs to the Drug Manufacturers business sector.

COVACERT is a brand of Amgen (AMGN) Share price

International deposit : 2007 Business sector Drug Manufacturers

Share price and profitability of the share Amgen (COVACERT)

Buy Amgen share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 264.07

Portfolio valuation
Amgen (COVACERT) over 5 years* USD 392.06

Stock market history Amgen (COVACERT)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Amgen

Tepezza
Tepezza
Viela Bio
Viela Bio
Abgenix
Abgenix
BioVex
BioVex
Immunex
Immunex
Avidia
Avidia
See more brands of Amgen

Rival brands
COVACERT

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS